BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE) has appointed biotech

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor , President and Chief Executive Officer of OncoSec, will present a company overview at the Virtual Summer Investor Summit on Tuesday, J

ROSEMONT, PA, June 4, 2020 /PRNewswire/ - Duchesnay USA, a pharmaceutical company that specializes in women’s health, is proud to announce the launch of a new video titled Straight Talk: Sex and the Menopausal Woman.

SurvivorNet, the country’s leading media company for cancer information, today announced it will host its latest virtual conference, “Key Developments in Multiple Myeloma in The Age of COVID-19 and Beyond,” on Thursday, June 4 at 5:30pm ET.

Weekly prizes aim to reduce migraine days for patients and culminate in a grand prize of the FDA-cleared medical device to mark National Migraine and Headache Awareness Month this June [04-June-2020] NEW YORK , June 4, 2020 /PRNewswire/ -- CEFALY , the first device of its kind to receive FDA medical clearance for migraine headaches, is launching a nationwide giveaway

Scality, a leader in software solutions for global data orchestration and distributed file and object storage today reported how the Scality RING brings unique efficiencies in today’s modern healthcare and genomic data centers.

Espero BioPharma, Inc., a pharmaceutical company focused on the development of therapeutics for unmet needs in thrombosis and cardiac rhythm control, today expanded a collaborative partnering effort for its lead product candidate tecarfarin. Tecarfarin is a Phase III-ready, vitamin K antagonist, taken once

DiscoveryBioMed, Inc . (DBM, www.discoverybiomed.com ) announces a new unit of its contract research organization (CRO) services business called TumorCube that is formed based upon our growing expertise in 3D Biogel-driven bioassays on diseased and normal human cell platform technologies. A trademark application has been filed. “DBM has a growing CRO services business in 3D Biogel-driven bioassays of diseased and

DexCom, Inc. announced that management will present an update on Dexcom at the following upcoming investor conference

John Wiley & Sons Inc. and the American Association for the Advancement of Science announced their collaboration to strengthen and support the Science Careers job board.